CytoMed Therapeutics Limited (GDTC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    CytoMed Therapeutics Limi...

    NASDAQ: GDTC · Real-Time Price · USD
    2.00
    0.03 (1.52%)
    At close: Sep 26, 2025, 3:57 PM
    1.95
    -2.50%
    After-hours: Sep 26, 2025, 04:00 PM EDT

    CytoMed Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 52.01K 290.56K 270.34K 84.18K
    Cost of Revenue
    		 567.82K 77.47K 6.48K 2.59K
    Gross Profit
    		 -515.82K 213.09K 263.86K 81.59K
    Operating Income
    		 -2.63M -2.91M -1.4M -1.43M
    Interest Income
    		 237.7K 38.73K 1.52K 2.51K
    Pretax Income
    		 -1.9M -3.13M -2.33M -1.53M
    Net Income
    		 -1.88M -3.13M -2.4M -1.53M
    Selling & General & Admin
    		 675.21K 1.93M 443.29K 435.31K
    Research & Development
    		 1.43M 1.2M 1.13M 806.45K
    Other Expenses
    		 7.7K n/a -195.32K 36.13K
    Operating Expenses
    		 2.11M 3.12M 1.38M 1.28M
    Interest Expense
    		 15.2K n/a 90.77K 87.58K
    Selling & Marketing Expenses
    		 n/a 25.24K n/a 1.83K
    Cost & Expenses
    		 3.2M 3.2M 1.38M 1.28M
    Income Tax Expense
    		 n/a 373.69 1.22K -53.43K
    Shares Outstanding (Basic)
    		 11.54M 10.63M 7.92M 6.93M
    Shares Outstanding (Diluted)
    		 11.54M 10.63M 7.92M 6.93M
    EPS (Basic)
    		 -0.16 -0.29 -0.3 -0.22
    EPS (Diluted)
    		 -0.16 -0.29 -0.3 -0.22
    EBITDA
    		 -1.79M -2.94M -1.11M -1.19M
    EBIT
    		 -1.88M -3.02M -2.91M -1.71M
    Depreciation & Amortization
    		 91.59K 77.47K 291.84K 243.92K

    Add to Watchlist